Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Corum Group Limited ( (AU:PHX) ) has provided an update.
PharmX Technologies Limited announced the cessation of 3,500,000 performance rights due to unmet conditions, impacting its issued capital. This development may influence the company’s financial structuring and strategic planning, potentially affecting stakeholders’ perceptions and the company’s market positioning.
More about Corum Group Limited
PharmX Technologies Limited operates within the technology sector, focusing on developing innovative solutions for the pharmaceutical industry. The company is primarily engaged in providing technology-driven services and products that enhance the efficiency and effectiveness of pharmaceutical operations.
Average Trading Volume: 862,161
Technical Sentiment Signal: Buy
Current Market Cap: A$77.81M
For an in-depth examination of PHX stock, go to TipRanks’ Overview page.